Reader Response: Clinical Significance of Anti-NMDAR Concurrent With Glial or Neuronal Surface Antibodies
- PMID: 33495393
- DOI: 10.1212/WNL.0000000000011361
Reader Response: Clinical Significance of Anti-NMDAR Concurrent With Glial or Neuronal Surface Antibodies
Comment in
-
Author Response: Clinical Significance of Anti-NMDAR Concurrent With Glial or Neuronal Surface Antibodies.Neurology. 2021 Jan 26;96(4):188-189. doi: 10.1212/WNL.0000000000011359. Neurology. 2021. PMID: 33495395 No abstract available.
Comment on
-
Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies.Neurology. 2020 Jun 2;94(22):e2302-e2310. doi: 10.1212/WNL.0000000000009239. Epub 2020 Mar 11. Neurology. 2020. PMID: 32161029
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources